BRIEF published on 11/14/2024 at 19:05, 6 days 18 hours ago Forbo Holding Ltd Announces Board of Directors Change Board Of Directors Leadership Change Forbo Holding This E. Schneider Bernhard Merki
PRESS RELEASE published on 11/14/2024 at 19:00, 6 days 18 hours ago Change on the Board of Directors of Forbo Holding Ltd Forbo Holding Ltd announces change on the Board of Directors with E. Schneider not standing for re-election and Bernhard Merki proposed as new Chairman. The company thanks Schneider for his contributions and strategic leadership Board Of Directors Chairman Bernhard Merki Forbo Holding Ltd E. Schneider
BRIEF published on 07/26/2024 at 06:05, 3 months 26 days ago Forbo Holding AG Reports Decline in H1 2024 Earnings Amid Challenging Market Conditions Net Sales EBIT Half-year Results Currency Effects Forbo
PRESS RELEASE published on 07/26/2024 at 06:00, 3 months 26 days ago FIRST HALF-YEAR 2024 Forbo Holding AG reports decline in net sales and earnings for the first half of 2024 due to market challenges and negative currency effects. EBIT margins maintained, equity ratio improved Net Sales Earnings Currency Effects Forbo Holding AG EBIT Margins
BRIEF published on 04/05/2024 at 18:50, 7 months 15 days ago Forbo Holding AG Shareholders Approve All Board Proposals at Ordinary General Meeting Sustainability Corporate Governance Dividends Forbo Holding AG Shareholders Meeting
PRESS RELEASE published on 04/05/2024 at 18:45, 7 months 15 days ago Forbo shareholders approve all proposals of the Board of Directors Forbo Holding AG's shareholders approve all proposals of the Board of Directors at the 96th Ordinary General Meeting, including a dividend of CHF 25 per share Board Of Directors Shareholders Dividend General Meeting Forbo Holding AG
BRIEF published on 03/05/2024 at 06:05, 8 months 16 days ago Forbo Holding AG Reports Business Performance for 2023 2024 Outlook Market Challenges Financial Results 2023 Forbo Holding AG Sustainability Initiatives
PRESS RELEASE published on 03/05/2024 at 06:00, 8 months 16 days ago BUSINESS YEAR 2023 Forbo Holding AG reports slight decline in net sales and operating profit for business year 2023. Group profit slightly higher. Dividend CHF 25 per share announced Operating Profit Net Sales Dividend Forbo Holding AG Business Year 2023
PRESS RELEASE published on 10/25/2023 at 06:45, 1 year ago Negative currency effects and reduced market dynamics impact business performance in the third quarter of 2023, lowering expectations for the year overall
PRESS RELEASE published on 07/28/2023 at 06:00, 1 year 3 months ago Solid result in difficult market environment
Published on 11/21/2024 at 13:00, 28 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 28 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 28 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 53 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 13 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 30 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 8 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
